Tedisamil Uses, Dosage, Side Effects and more
Tedisamil (planned trade name Pulzium) is an investigational drug for atrial fibrillation and atrial flutter. It is currently being developed by Solvay and is currently under regulatory review by the United States Food and Drug Administration.
| Trade Name | Tedisamil |
| Generic | Tedisamil |
| Tedisamil Other Names | Tedisamil |
| Type | |
| Formula | C19H32N2 |
| Weight | Average: 288.4708 Monoisotopic: 288.256549034 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in arrhythmia, atrial fibrillation, and angina.
How Tedisamil works
It is hypothesized tedisamil prevents Ca2+ overload by the cAMP dependent SR Ca2+ uptake [PMID: 10707827].
